BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CDH11, OB, 1009, ENSG00000140937, CAD11, P55287 AND Treatment
19 results:

  • 1. Title: Obesogenic microbial signatures and the development of obesity in childhood acute lymphoblastic leukemia.
    Park H; Uhlemann AC; Jacobs SS; Mowbray C; Jubelirer T; Kelly KM; Walters M; Ladas EJ
    Leuk Res; 2023 Mar; 126():107017. PubMed ID: 36641874
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL).
    Al-Sawaf O; Bazeos A; Robrecht S; Bahlo J; Gower C; Fink AM; Tresckow J; Cramer P; Langerbeins P; Kutsch N; Humphrey K; Fingerle-Rowson G; Stilgenbauer S; Wendtner CM; Fischer K; Eichhorst B; Hallek M; Goede V
    Am J Hematol; 2019 Sep; 94(9):1002-1006. PubMed ID: 31222797
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Discovery of donor genotype associated with long-term survival of patients with hematopoietic stem cell transplantation in refractory acute myeloid leukemia.
    Ock CY; Seo H; Kim DY; Min BJ; Park Y; Cheong HS; Kim HL; Song EY; Kim I; Yoon SS; Kim JH; Koh Y
    Leuk Lymphoma; 2019 Jul; 60(7):1775-1781. PubMed ID: 30507323
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia.
    Al-Sawaf O; Bahlo J; Robrecht S; Fischer K; Herling CD; Hoechstetter M; Fink AM; von Tresckow J; Langerbeins P; Cramer P; Stilgenbauer S; Wendtner CM; Eichhorst B; Hallek M; Goede V
    Br J Haematol; 2018 Dec; 183(5):727-735. PubMed ID: 30460980
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ADAMTSL5 and cdh11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia.
    Abdullah M; Choo CW; Alias H; Abdul Rahman EJ; Mohd Ibrahim H; Jamal R; Hussin NH
    Hematology; 2017 Aug; 22(7):386-391. PubMed ID: 28292214
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Tax-targeted DC vaccine for ATL].
    Suehiro Y
    Nihon Rinsho; 2017 Feb; 75(2):295-300. PubMed ID: 30562867
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.
    Mantha S; Goldman DA; Devlin SM; Lee JW; Zannino D; Collins M; Douer D; Iland HJ; Litzow MR; Stein EM; Appelbaum FR; Larson RA; Stone R; Powell BL; Geyer S; Laumann K; Rowe JM; Erba H; Coutre S; Othus M; Park JH; Wiernik PH; Tallman MS
    Blood; 2017 Mar; 129(13):1763-1767. PubMed ID: 28082441
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Physical Activity in Long-term Survivors of Acute Lymphoblastic leukemia in Childhood and Adolescence: A Cross-sectional Cohort Study.
    Nayiager T; Barr RD; Anderson L; Cranston A; Hay J
    J Pediatr Hematol Oncol; 2017 Jan; 39(1):15-19. PubMed ID: 27571119
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Mucormycosis during Imatinib treatment: case report.
    Crisan AM; Ghiaur A; Stancioaca MC; Bardas A; Ghita C; Manea CM; Ionescu B; Coriu D
    J Med Life; 2015; 8(3):365-70. PubMed ID: 26351543
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts.
    Dombret H; Seymour JF; Butrym A; Wierzbowska A; Selleslag D; Jang JH; Kumar R; Cavenagh J; Schuh AC; Candoni A; Récher C; Sandhu I; Bernal del Castillo T; Al-Ali HK; Martinelli G; Falantes J; Noppeney R; Stone RM; Minden MD; McIntyre H; Songer S; Lucy LM; Beach CL; Döhner H
    Blood; 2015 Jul; 126(3):291-9. PubMed ID: 25987659
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Leptin reverts pro-apoptotic and antiproliferative effects of α-linolenic acids in BCR-ABL positive leukemic cells: involvement of PI3K pathway.
    Beaulieu A; Poncin G; Belaid-Choucair Z; Humblet C; Bogdanovic G; Lognay G; Boniver J; Defresne MP
    PLoS One; 2011; 6(10):e25651. PubMed ID: 21991326
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.
    Stork LC; Matloub Y; Broxson E; La M; Yanofsky R; Sather H; Hutchinson R; Heerema NA; Sorrell AD; Masterson M; Bleyer A; Gaynon PS
    Blood; 2010 Apr; 115(14):2740-8. PubMed ID: 20124218
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Bcl-2 in combination to myeloid antigen expression in adult acute lymphoblastic leukemia and prognostic outcome.
    Amirghofran Z; Daneshbod Y; Gholijani N
    Oncol Res; 2009; 17(10):447-54. PubMed ID: 19725224
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study.
    Larson RA; Druker BJ; Guilhot F; O'Brien SG; Riviere GJ; Krahnke T; Gathmann I; Wang Y;
    Blood; 2008 Apr; 111(8):4022-8. PubMed ID: 18256322
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.
    Matloub Y; Lindemulder S; Gaynon PS; Sather H; La M; Broxson E; Yanofsky R; Hutchinson R; Heerema NA; Nachman J; Blake M; Wells LM; Sorrell AD; Masterson M; Kelleher JF; Stork LC;
    Blood; 2006 Aug; 108(4):1165-73. PubMed ID: 16609069
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Leptin-induced increase in leukemia inhibitory factor and its receptor by human endometrium is partially mediated by interleukin 1 receptor signaling.
    Gonzalez RR; Rueda BR; Ramos MP; Littell RD; Glasser S; Leavis PC
    Endocrinology; 2004 Aug; 145(8):3850-7. PubMed ID: 15142989
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Leptin and the pituitary.
    Sone M; Osamura RY
    Pituitary; 2001; 4(1-2):15-23. PubMed ID: 11824504
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. treatment and survival of lymphoid malignancy in the north-west of England: a population-based study.
    Youngson JH; Jones JM; Chang JG; Harris M; Banergee SS
    Br J Cancer; 1995 Sep; 72(3):757-65. PubMed ID: 7669590
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Late effects of x irradiation in patients treated for metropathia haemorrhagica.
    Smith PG; Doll R
    Br J Radiol; 1976 Mar; 49(579):224-32. PubMed ID: 1276589
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.